Objective: To evaluate the benefit of an axillary surgical approach on overall survival in patients with metastatic breast cancer. Summary background data: Metastatic breast cancer at diagnosis is considered to be an incurable disease, and systemic treatment is indicated. However, several retrospective studies have shown that local treatment is an independent factor in improving overall survival, but this issue is still controversial. Methods: Systematic review with literature searches in MEDLINE (by PubMed), EMBASE, Clinical Trials, Scopus, Web of Science, SciELO, Lilacs, Google Scholar and Proquest electronic databases, and gray literature without restrictions on date, language or study design. Study selection and data extraction were performed independently by two authors. Data were summarized through meta-analyses using a random effects model and considered hazard ratio (HR) measures and their confidence intervals (95%CI). Results: After eligibility assessment, we included 16 studies in the systematic review, encompassing a total of 16,692 patients. Twelve studies were used in the quantitative analysis. The studies included in this review seemed to have overall good methodological quality. There was no association between an axillary surgical approach and overall survival (HR= 0.82; 95%CI 0.60-1.13). We identified as a secondary finding that there was a benefit from a breast surgical approach related to overall survival in patients with metastatic breast cancer (HR 0.70; 95%CI 0.60-0.82). Conclusion: An axillary surgical approach showed no association with overall survival in patients with metastatic breast cancer, but the breast surgical approach seemed to show a benefit in terms of overall survival. The true impact of locoregional therapies on long-term outcomes remains unknown, and randomized clinical trials are needed.
A mastectomia nipple-sparing (MNS) e a conservação do complexo aréolo-papilar (CAP) representam uma manobra terapêutica do câncer de mama com melhor resultado estético, impacto positivo na imagem corporal e mais satisfação do que a reconstrução do CAP. Questiona-se a indicação de radioterapia quando da manutenção do CAP e seu potencial prejuízo estético. Objetivo: Examinar a indicação de radioterapia em MNS e, secundariamente, a incidência do envolvimento do CAP e as taxas de recorrência local. Métodos: Revisão sistemática realizada na base de dados do PubMed com os termos ("breast neoplasm" [Mesh] OR "breast cancer") AND ("radiotherapy" OR "radiation therapy") AND ("nipple sparing mastectomy" OR "mastectomies" OR "subcutaneous mastectomies"). A seleção dos estudos, a avaliação da qualidade do estudo e a extração de dados foram realizadas de forma independente por quatro revisores. Resultados: As indicações para radioterapia após MNS foram: axila positiva, tumores acima de 5 cm e tecido retroareolar remanescente maior que 5 mm. O envolvimento do CAP ocorreu em 5 a 26,1% no anatomopatológico definitivo. A recorrência no CAP ocorreu de 2,59 a 10%. A necrose do CAP ocorreu em 2,2 a 43,4%. Conclusão: As indicações de radioterapia para MNS parecem seguir as mesmas indicações clássicas para radioterapia após mastectomia. O índice de recidiva no CAP não mostrou ser maior com uso de radioterapia nem ter diferença quanto ao seu tipo. A decisão de realizar a radioterapia deve se basear em fatores que sugerem alto risco para envolvimento do CAP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.